Legal battle brewing over Novo Nordisk's Ozempic patent in India
A major legal battle is brewing in India's pharmaceutical sector, as generic drugmaker Dr. Reddy's Laboratories challenges Novo Nordisk's patent for semaglutide — the active ingredient in the popular diabetes and...To view the full article, register now.
Already a subscriber? Click here to view full article